Poland· PL-100127134
Levemir
A insulin detemir product containing insulinum detemirum, registered in Poland by Novo Nordisk A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Insulin detemir is registered in 14 of 19 countries.
Countries holding a registration under ATC A10AE05 (insulin detemir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Insulin detemir · ATC A10AE05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Insulinum detemirum
- Manufacturer
- Novo Nordisk A/S
- Country
- Poland (PL)
- ATC code
- A10AE05
- ATC class
- Insulin detemir
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
1 priced- gtin05909990008193
- gtin059099900057415 wkł.po 3 mlPLN 207.29
- gtin05909990008186
- gtin05909990008209
- gtin05909990008155
- gtin05909990008179
- gtin05909990008223
- gtin05909990008230
- gtin05909990008247
- gtin05909990008162
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin detemir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin detemir · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Insulin detemir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEVEMIR FLEXPENNovo Nordisk A/S, Bagsvaerd
- United KingdomLevemir FlexPen 100units/ml solution for injection 3ml pre-filled pensWaymade Healthcare Plc
- FinlandLevemir FlexpenOrifarm Oy
- United StatesLevemirNovo Nordisk
- BelgiumLevemir 100 U/mlNovo Nordisk
- IcelandLevemir FlexpenNovo Nordisk A/S*
- NetherlandsLevemir Flexpen 100 eenheden/ml oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- SwedenLevemir (FlexPen) 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Levemir Flexpen, Levemir Flextouch
- Norway · Levemir Flexpen, Levemir Flextouch
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc25deb5-9cc0-4201-83eb-78df2ce0fb28 GET /v1/drugs/bc25deb5-9cc0-4201-83eb-78df2ce0fb28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "100 j./ml",
"packaging": "05909990008186 ¦ Rp ¦ EU/1/04/278/004 ¦ 24215\n1 wstrzykiwacz 3 ml\n05909990008193 ¦ Rp ¦ EU/1/04/278/005 ¦ 24216\n5 wstrzykiwaczy 3 ml\n05909990008209 ¦ Rp ¦ EU/1/04/278/006 ¦ 24217\n10 wstrzykiwaczy 3 ml\nRp ¦ EU/1/04/278/010 ¦ 104994\n1 wstrzykiwacz 3 ml ¦ 7 igieł NovoFine\nRp ¦ EU/1/04/278/011 ¦ 104995\n1 wstrzykiwacz 3 ml ¦ 7 igieł NovoTwist\nRp ¦ EU/1/04/278/012 ¦ 107711\n1 wstrzykiwacz 3 ml FlexTouch\nRp ¦ EU/1/04/278/013 ¦ 107712\n5 wstrzykiwaczy 3 ml FlexTouch\nRp ¦ EU/1/04/278/014 ¦ 107713\n10 wstrzykiwaczy 3 ml FlexTouch\nRp ¦ EU/1/04/278/015 ¦ 107714\n1 wstrzykiwacz 3 ml FlexTouch ¦ 7 igieł NovoFine\nRp ¦ EU/1/04/278/016 ¦ 107715\n1 wstrzykiwacz 3 ml FlexTouch ¦ 7 igieł NovoTwist\n05909990008155 ¦ Rp ¦ EU/1/04/278/001 ¦ 107716\n1 wkład 3 ml Penfill\n05909990005741 ¦ Rp ¦ EU/1/04/278/002 ¦ 107717\n5 wkładów 3 ml Penfill\n05909990008179 ¦ Rp ¦ EU/1/04/278/003 ¦ 107718\n10 wkładów 3 ml Penfill\n05909990008223 ¦ Rp ¦ EU/1/04/278/007 ¦ 107719\n1 wstrzykiwacz 3 ml\n05909990008230 ¦ Rp ¦ EU/1/04/278/008 ¦ 107720\n5 wstrzykiwaczy 3 ml\n05909990008247 ¦ Rp ¦ EU/1/04/278/009 ¦ 107721\n10 wstrzykiwaczy 3 ml\n05909990008162 ¦ Rp ¦ Skasowane ¦ 107723\n5 wkładów",
"substance": "Insulinum detemirum 100 j./1 ml",
"common_name": "Insulinum detemirum",
"pl_product_id": "100127134",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about insulin detemir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.